FORT LAUDERDALE, Fla. — Despite efforts to promote more diverse patient populations, racial minority patient groups are underrepresented in diabetic macular edema trials, according to a study.
In a presentation at the Retina World Congress, Jay Chhablani, MD, said The NIH Revitalization Act of 1993 mandated the inclusion of racial minority groups and women in clinical trials. However, only a small amount of trials have enrolled a sufficient amount of patients from minority groups or reported outcomes by race.
“Nonwhite racial and ethnic subgroups are frequently underrepresented in